60 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Uzungil V, Luza S, Opazo CM, Mees I, Li S, Ang CS, Williamson NA, Bush AI, Hannan AJ, Renoir T. Phosphoproteomics implicates glutamatergic and dopaminergic signalling in the antidepressant-like properties of the iron chelator deferiprone. Neuropharmacology. 109837. PMID 38184274 DOI: 10.1016/j.neuropharm.2024.109837  0.642
2023 Gubert C, Kong G, Costello C, Adams CD, Masson BA, Qin W, Choo J, Narayana VK, Rogers G, Renoir T, Furness JB, Hannan AJ. Dietary fibre confers therapeutic effects in a preclinical model of Huntington's disease. Brain, Behavior, and Immunity. 116: 404-418. PMID 38142919 DOI: 10.1016/j.bbi.2023.12.023  0.831
2023 Wilson C, Hannan AJ, Renoir T. Serotonergic agonism and pharmacologically-induced adolescent stress cause operant-based learning deficits in mice. Neuropharmacology. 109801. PMID 38040286 DOI: 10.1016/j.neuropharm.2023.109801  0.67
2023 Gattuso JJ, Wilson C, Hannan AJ, Renoir T. Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review. Journal of Neurochemistry. PMID 38019032 DOI: 10.1111/jnc.16017  0.63
2023 Gattuso JJ, Wilson C, Hannan AJ, Renoir T. Acute administration of the NMDA receptor antagonists ketamine and MK-801 reveals dysregulation of glutamatergic signalling and sensorimotor gating in the Sapap3 knockout mouse model of compulsive-like behaviour. Neuropharmacology. 109689. PMID 37597609 DOI: 10.1016/j.neuropharm.2023.109689  0.672
2023 Wilson C, Gattuso J, Hannan AJ, Renoir T. Mechanisms of pathogenesis and environmental moderators in preclinical models of compulsive-like behaviours. Neurobiology of Disease. 106223. PMID 37423502 DOI: 10.1016/j.nbd.2023.106223  0.645
2023 Mees I, Nisbet RM, Hannan AJ, Renoir T. Implications of Tau Dysregulation in Huntington's Disease and Potential for New Therapeutics. Journal of Huntington's Disease. 12: 1-13. PMID 37092231 DOI: 10.3233/JHD-230569  0.664
2023 Leembruggen AJL, Lu Y, Wang H, Uzungil V, Renoir T, Hannan AJ, Stamp LA, Hao MM, Bornstein JC. Group I Metabotropic Glutamate Receptors Modulate Motility and Enteric Neural Activity in the Mouse Colon. Biomolecules. 13. PMID 36671524 DOI: 10.3390/biom13010139  0.599
2022 Mees I, Li S, Tran H, Ang CS, Williamson NA, Hannan AJ, Renoir T. Phosphoproteomic dysregulation in Huntington's disease mice is rescued by environmental enrichment. Brain Communications. 4: fcac305. PMID 36523271 DOI: 10.1093/braincomms/fcac305  0.703
2022 Farzana F, McConville MJ, Renoir T, Li S, Nie S, Tran H, Hannan AJ, Hatters DM, Boughton BA. Longitudinal spatial mapping of lipid metabolites reveals pre-symptomatic changes in the hippocampi of Huntington's disease transgenic mice. Neurobiology of Disease. 176: 105933. PMID 36436748 DOI: 10.1016/j.nbd.2022.105933  0.678
2022 Love CJ, Gubert C, Renoir T, Hannan AJ. Environmental enrichment and exercise housing protocols for mice. Star Protocols. 3: 101689. PMID 36125931 DOI: 10.1016/j.xpro.2022.101689  0.778
2022 Gubert C, Choo JM, Love CJ, Kodikara S, Masson BA, Liew JJM, Wang Y, Kong G, Narayana VK, Renoir T, Lê Cao KA, Rogers GB, Hannan AJ. Faecal microbiota transplant ameliorates gut dysbiosis and cognitive deficits in Huntington's disease mice. Brain Communications. 4: fcac205. PMID 36035436 DOI: 10.1093/braincomms/fcac205  0.828
2022 Uzungil V, Tran H, Aitken C, Wilson C, Opazo CM, Li S, Payet JM, Mawal CH, Bush AI, Hale MW, Hannan AJ, Renoir T. Novel Antidepressant-Like Properties of the Iron Chelator Deferiprone in a Mouse Model of Depression. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 35861925 DOI: 10.1007/s13311-022-01257-0  0.654
2022 Mees I, Tran H, Roberts A, Lago L, Li S, Roberts BR, Hannan AJ, Renoir T. Quantitative Phosphoproteomics Reveals Extensive Protein Phosphorylation Dysregulation in the Cerebral Cortex of Huntington's Disease Mice Prior to Onset of Symptoms. Molecular Neurobiology. PMID 35083661 DOI: 10.1007/s12035-021-02698-y  0.675
2022 Mees I, Li S, Beauchamp LC, Barnham KJ, Dutschmann M, Hannan AJ, Renoir T. Loss-of-function and gain-of-function studies refute the hypothesis that tau protein is causally involved in the pathogenesis of Huntington's disease. Human Molecular Genetics. PMID 34999772 DOI: 10.1093/hmg/ddac001  0.686
2021 Gubert C, Love CJ, Kodikara S, Mei Liew JJ, Renoir T, Lê Cao KA, Hannan AJ. Gene-environment-gut interactions in Huntington's disease mice are associated with environmental modulation of the gut microbiome. Iscience. 25: 103687. PMID 35059604 DOI: 10.1016/j.isci.2021.103687  0.83
2021 Wilson C, Rogers J, Chen F, Li S, Adlard PA, Hannan AJ, Renoir T. Exercise ameliorates aberrant synaptic plasticity without enhancing adult-born cell survival in the hippocampus of serotonin transporter knockout mice. Brain Structure & Function. PMID 34052925 DOI: 10.1007/s00429-021-02283-y  0.81
2021 Dubois C, Kong G, Tran H, Li S, Pang TY, Hannan AJ, Renoir T. Small Non-coding RNAs Are Dysregulated in Huntington's Disease Transgenic Mice Independently of the Therapeutic Effects of an Environmental Intervention. Molecular Neurobiology. PMID 33675499 DOI: 10.1007/s12035-021-02342-9  0.788
2020 Kong G, Ellul S, Narayana VK, Kanojia K, Ha HTT, Li S, Renoir T, Cao KL, Hannan AJ. An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington's disease. Neurobiology of Disease. 105199. PMID 33249136 DOI: 10.1016/j.nbd.2020.105199  0.811
2020 Gubert C, Kong G, Uzungil V, Zeleznikow-Johnston AM, Burrows EL, Renoir T, Hannan AJ. Microbiome Profiling Reveals Gut Dysbiosis in the Metabotropic Glutamate Receptor 5 Knockout Mouse Model of Schizophrenia. Frontiers in Cell and Developmental Biology. 8: 582320. PMID 33195226 DOI: 10.3389/fcell.2020.582320  0.775
2020 Gubert C, Renoir T, Hannan AJ. Why Woody got the blues: The neurobiology of depression in Huntington's disease. Neurobiology of Disease. 104958. PMID 32526274 DOI: 10.1016/J.Nbd.2020.104958  0.795
2020 Kuznetsova M, Wilson C, Hannan AJ, Renoir T. How the enriched get richer? Experience-dependent modulation of microRNAs and the therapeutic effects of environmental enrichment. Pharmacology, Biochemistry, and Behavior. 172940. PMID 32413435 DOI: 10.1016/J.Pbb.2020.172940  0.648
2020 Wilson C, Li S, Hannan AJ, Renoir T. Antidepressant-like effects of ketamine in a mouse model of serotonergic dysfunction. Neuropharmacology. 107998. PMID 32061666 DOI: 10.1016/J.Neuropharm.2020.107998  0.674
2019 Gubert C, Kong G, Renoir T, Hannan AJ. Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases. Neurobiology of Disease. 104621. PMID 31628992 DOI: 10.1016/J.Nbd.2019.104621  0.799
2019 Ayton S, Lei P, Appukuttan AT, Renoir T, Foliaki S, Chen F, Adlard PA, Hannan AJ, Bush AI. Brain Zinc Deficiency Exacerbates Cognitive Decline in the R6/1 Model of Huntington's Disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 31520307 DOI: 10.1007/S13311-019-00785-6  0.694
2019 Rogers J, Chen F, Stanic D, Farzana F, Li S, Zeleznikow-Johnston AM, Nithianantharajah J, Churilov L, Adlard PA, Lanfumey L, Hannan AJ, Renoir T. Paradoxical effects of exercise on hippocampal plasticity and cognition in mice with a heterozygous null mutation in the serotonin transporter gene. British Journal of Pharmacology. PMID 31167040 DOI: 10.1111/Bph.14760  0.777
2019 Rogers J, Renoir T, Hannan AJ. Gene-environment interactions informing therapeutic approaches to cognitive and affective disorders. Neuropharmacology. 145: 37-48. PMID 29277490 DOI: 10.1016/J.Neuropharm.2017.12.038  0.807
2018 Zajac MS, Renoir T, Perreau VM, Li S, Adams W, van den Buuse M, Hannan AJ. Short-Term Environmental Stimulation Spatiotemporally Modulates Specific Serotonin Receptor Gene Expression and Behavioral Pharmacology in a Sexually Dimorphic Manner in Huntington's Disease Transgenic Mice. Frontiers in Molecular Neuroscience. 11: 433. PMID 30618600 DOI: 10.3389/Fnmol.2018.00433  0.691
2018 Zeleznikow-Johnston AM, Renoir T, Churilov L, Li S, Burrows EL, Hannan AJ. Touchscreen testing reveals clinically relevant cognitive abnormalities in a mouse model of schizophrenia lacking metabotropic glutamate receptor 5. Scientific Reports. 8: 16412. PMID 30401923 DOI: 10.1038/S41598-018-33929-3  0.804
2018 Kong G, Cao KL, Judd LM, Li S, Renoir T, Hannan AJ. Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease. Neurobiology of Disease. PMID 30194046 DOI: 10.1016/J.Nbd.2018.09.001  0.84
2018 Rawat A, Guo J, Renoir T, Pang TY, Hannan AJ. Hypersensitivity to sertraline in the absence of hippocampal 5-HTR and 5-HTT gene expression changes following paternal corticosterone treatment. Environmental Epigenetics. 4: dvy015. PMID 30046455 DOI: 10.1093/Eep/Dvy015  0.783
2017 Wright DJ, Renoir T, Gray LJ, Hannan AJ. Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets. Advances in Neurobiology. 15: 93-128. PMID 28674979 DOI: 10.1007/978-3-319-57193-5_4  0.737
2017 Rogers J, Li S, Lanfumey L, Hannan AJ, Renoir T. Environmental enrichment reduces innate anxiety with no effect on depression-like behaviour in mice lacking the serotonin transporter. Behavioural Brain Research. PMID 28629963 DOI: 10.1016/J.Bbr.2017.06.009  0.822
2017 Yeshurun S, Rogers J, Short AK, Renoir T, Pang TY, Hannan AJ. Elevated paternal glucocorticoid exposure modifies memory retention in female offspring. Psychoneuroendocrinology. 83: 9-18. PMID 28554167 DOI: 10.1016/J.Psyneuen.2017.05.014  0.782
2017 Zeleznikow-Johnston A, Burrows EL, Renoir T, Hannan AJ. Environmental enrichment enhances cognitive flexibility in C57BL/6 mice on a touchscreen reversal learning task. Neuropharmacology. PMID 28196627 DOI: 10.1016/J.Neuropharm.2017.02.009  0.797
2016 Rogers J, Churilov L, Hannan AJ, Renoir T. Search strategy selection in the Morris water maze indicates allocentric map formation during learning that underpins spatial memory formation. Neurobiology of Learning and Memory. PMID 27988312 DOI: 10.1016/J.Nlm.2016.12.007  0.775
2016 Wright DJ, Gray LJ, Finkelstein DI, Crouch PJ, Pow D, Pang T, Li S, Smith ZM, Francis PS, Renoir T, Hannan AJ. N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington's disease. Human Molecular Genetics. PMID 27179791 DOI: 10.1093/Hmg/Ddw144  0.808
2015 Renoir T, Pang TY, Shikano Y, Li S, Hannan AJ. Loss of the Sexually Dimorphic Neuro-Inflammatory Response in a Transgenic Mouse Model of Huntington's Disease. Journal of Huntington's Disease. PMID 26599196 DOI: 10.3233/Jhd-150153  0.784
2015 Mo C, Renoir T, Hannan AJ. What's wrong with my mouse cage? Methodological considerations for modeling lifestyle factors and gene-environment interactions in mice. Journal of Neuroscience Methods. PMID 26279343 DOI: 10.1016/J.Jneumeth.2015.08.008  0.808
2015 Mo C, Hannan AJ, Renoir T. Environmental factors as modulators of neurodegeneration: insights from gene-environment interactions in Huntington's disease. Neuroscience and Biobehavioral Reviews. 52: 178-92. PMID 25770041 DOI: 10.1016/J.Neubiorev.2015.03.003  0.838
2015 Mo C, Renoir T, Hannan AJ. Novel ethological endophenotypes in a transgenic mouse model of Huntington's disease. Behavioural Brain Research. 276: 17-27. PMID 24747660 DOI: 10.1016/J.Bbr.2014.04.003  0.823
2014 Renoir T, Argyropoulos A, Chevarin C, Lanfumey L, Hannan AJ. Sexually dimorphic dopaminergic dysfunction in a transgenic mouse model of Huntington's disease. Pharmacology, Biochemistry, and Behavior. 127: 15-20. PMID 25316307 DOI: 10.1016/J.Pbb.2014.10.004  0.695
2014 Mazarakis NK, Mo C, Renoir T, van Dellen A, Deacon R, Blakemore C, Hannan AJ. 'Super-Enrichment' Reveals Dose-Dependent Therapeutic Effects of Environmental Stimulation in a Transgenic Mouse Model of Huntington's Disease. Journal of Huntington's Disease. 3: 299-309. PMID 25300333 DOI: 10.3233/Jhd-140118  0.813
2014 Mo C, Renoir T, Hannan AJ. Ethological endophenotypes are altered by elevated stress hormone levels in both Huntington's disease and wildtype mice. Behavioural Brain Research. 274: 118-27. PMID 25101541 DOI: 10.1016/J.Bbr.2014.07.044  0.84
2014 Mo C, Renoir T, Hannan AJ. Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice. Neurobiology of Disease. 71: 81-94. PMID 25088714 DOI: 10.1016/J.Nbd.2014.07.008  0.836
2014 Mo C, Pang TY, Ransome MI, Hill RA, Renoir T, Hannan AJ. High stress hormone levels accelerate the onset of memory deficits in male Huntington's disease mice. Neurobiology of Disease. 69: 248-62. PMID 24825316 DOI: 10.1016/J.Nbd.2014.05.004  0.825
2013 Renoir T, Hasebe K, Gray L. Mind and body: how the health of the body impacts on neuropsychiatry. Frontiers in Pharmacology. 4: 158. PMID 24385966 DOI: 10.3389/fphar.2013.00158  0.499
2013 Mo C, Renoir T, Pang TY, Hannan AJ. Short-term memory acquisition in female Huntington's disease mice is vulnerable to acute stress. Behavioural Brain Research. 253: 318-22. PMID 23916759 DOI: 10.1016/J.Bbr.2013.07.041  0.825
2013 Pang TY, Du X, Catchlove WA, Renoir T, Lawrence AJ, Hannan AJ. Positive environmental modification of depressive phenotype and abnormal hypothalamic-pituitary-adrenal axis activity in female C57BL/6J mice during abstinence from chronic ethanol consumption. Frontiers in Pharmacology. 4: 93. PMID 23898297 DOI: 10.3389/Fphar.2013.00093  0.783
2013 Pang TY, Renoir T, Du X, Lawrence AJ, Hannan AJ. Depression-related behaviours displayed by female C57BL/6J mice during abstinence from chronic ethanol consumption are rescued by wheel-running. The European Journal of Neuroscience. 37: 1803-10. PMID 23551162 DOI: 10.1111/Ejn.12195  0.772
2013 Renoir T, Pang TY, Mo C, Chan G, Chevarin C, Lanfumey L, Hannan AJ. Differential effects of early environmental enrichment on emotionality related behaviours in Huntington's disease transgenic mice. The Journal of Physiology. 591: 41-55. PMID 23045340 DOI: 10.1113/Jphysiol.2012.239798  0.796
2013 Renoir T, Pang TY, Hannan AJ. Effects of environmental manipulations in genetically targeted animal models of affective disorders. Neurobiology of Disease. 57: 12-27. PMID 22525570 DOI: 10.1016/J.Nbd.2012.04.003  0.778
2012 Renoir T, Argyropoulos A, Hannan AJ. Antidepressant-Like Effect of the Norepinephrine-Dopamine Reuptake Inhibitor Bupropion in a Mouse Model of Huntington's Disease with Dopaminergic Dysfunction. Journal of Huntington's Disease. 1: 261-6. PMID 25063334 DOI: 10.3233/Jhd-120039  0.663
2012 Ransome MI, Renoir T, Hannan AJ. Hippocampal neurogenesis, cognitive deficits and affective disorder in Huntington's disease. Neural Plasticity. 2012: 874387. PMID 22830053 DOI: 10.1155/2012/874387  0.723
2012 Howard ML, Palmer SJ, Taylor KM, Arthurson GJ, Spitzer MW, Du X, Pang TY, Renoir T, Hardeman EC, Hannan AJ. Mutation of Gtf2ird1 from the Williams-Beuren syndrome critical region results in facial dysplasia, motor dysfunction, and altered vocalisations. Neurobiology of Disease. 45: 913-22. PMID 22198572 DOI: 10.1016/J.Nbd.2011.12.010  0.796
2012 Renoir T, Pang TY, Lanfumey L. Drug withdrawal-induced depression: serotonergic and plasticity changes in animal models. Neuroscience and Biobehavioral Reviews. 36: 696-726. PMID 22037449 DOI: 10.1016/j.neubiorev.2011.10.003  0.649
2012 Renoir T, Pang TY, Zajac MS, Chan G, Du X, Leang L, Chevarin C, Lanfumey L, Hannan AJ. Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise. British Journal of Pharmacology. 165: 1375-89. PMID 21718306 DOI: 10.1111/J.1476-5381.2011.01567.X  0.79
2011 Renoir T, Chevarin C, Lanfumey L, Hannan AJ. Effect of enhanced voluntary physical exercise on brain levels of monoamines in Huntington disease mice. Plos Currents. 3: RRN1281. PMID 22266953 DOI: 10.1371/Currents.Rrn1281  0.702
2011 Renoir T, Zajac MS, Du X, Pang TY, Leang L, Chevarin C, Lanfumey L, Hannan AJ. Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression. Plos One. 6: e22133. PMID 21760962 DOI: 10.1371/Journal.Pone.0022133  0.808
2010 Païzanis E, Renoir T, Lelievre V, Saurini F, Melfort M, Gabriel C, Barden N, Mocaër E, Hamon M, Lanfumey L. Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 759-74. PMID 19775499 DOI: 10.1017/S1461145709990514  0.334
Show low-probability matches.